Noble Life Sciences Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $100K
Latest Deal Amount
  • Investors
  • 3

Noble Life Sciences General Information

Description

Provider of GLP and non-GLP services intended to accelerate the development of drugs, vaccines and medical devices. The company's services offer experimental design and testing, early safety assessments, toxicology and vivarium services, enabling physicians to do safety and efficacy testing of any drug candidate.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Other Healthcare Services
Primary Office
  • PO Box 242
  • Woodbine, MD 21797
  • United States
+1 (800) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Noble Life Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 04-Dec-2013 $100K 00000 Completed Generating Revenue
2. Debt - General 11-Jun-2013 00000 Completed Generating Revenue
1. Seed Round 30-Mar-2012 $235K $235K Completed Generating Revenue
To view Noble Life Sciences’s complete valuation and funding history, request access »

Noble Life Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of GLP and non-GLP services intended to accelerate the development of drugs, vaccines and medical devices. The
Biotechnology
Woodbine, MD
00000
0000000000 00000

000 0000

tetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad
0000000000000
Burlingame, CA

000 0000

labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris ni
0000 000000000
Newark, DE
0000 As of 0000
000000000 -
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Noble Life Sciences Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PRC Clinical Corporation Burlingame, CA
000 00000000 Formerly PE-Backed Newark, DE 0000 000000000 -
000000 000000000 0 Private Equity-Backed Albany, NY 0000 000.00 000000000 000.00
0000000000 Private Equity-Backed Princeton, NJ 0000 00000 000000000 00000
000000 000000000 Venture Capital-Backed Exton, PA 00 00.00 000000000 - 00.00
You’re viewing 5 of 14 competitors. Get the full list »

Noble Life Sciences Executive Team (11)

Name Title Board Seat Contact Info
Srujana Cherukuri Ph.D Chief Executive Officer
Alain Cappeluti President
Trevor Lee Managing Director & Chief Financial Officer
Stephen Horrigan Ph.D Chief Scientific Officer
Kenneth Carter Ph.D Co-Founder & Chairman
You’re viewing 5 of 11 executive team members. Get the full list »

Noble Life Sciences Board Members (1)

Name Representing Role Since
Kenneth Carter Ph.D Noble Life Sciences Co-Founder & Chairman 000 0000
To view Noble Life Sciences’s complete board members history, request access »

Noble Life Sciences Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
TEDCO Venture Capital Minority 000 0000 000000 0
BroadOak Capital Partners Investment Bank Minority 000 0000 000000 0
Noble BioVentures Venture Capital Minority 000 0000 000000 0
To view Noble Life Sciences’s complete investors history, request access »

Noble Life Sciences Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000 0000 03-Dec-2014 000000000000000000 Other Healthcare Services 00000 000000000
SynAm Vaccine 16-Apr-2013 Grant 0000 Other Pharmaceuticals and Biotechnology
To view Noble Life Sciences’s complete investments and acquisitions history, request access »